In 2020, Pfizer Knew the Lipid Nanoparticles Would Migrate Away From the Arm and into systemic Lymph Nodes - WHISTLEBLOWER, Prof. Ulrike Kammerer
Harold Saive
In 2020, BioNTech CEO Ugur Sahin proudly
announced, "...we chose lipid nanoparticles that promote
migration from the muscle cells into the lymph nodes."
Source: "DIE PRESS", 9-02-2020, translated
from German to English. - https://tinyurl.com/2p8tscmx
"Depending on how these lipid nanoparticles are
constructed on the surface, they behave differently. Sahin:
"For the Covid-19 candidate vaccine, we chose lipid
nanoparticles that promote migration from the muscle cells
into the lymph nodes. Dendritic (antigen-presenting; note)
cells then present the resulting S-protein to the immune
system. We have in According to the early data published so
far, both a strong antibody reaction of the B cells and the
development of specific CD4-positive and CD8-positive T cells
were observed.The CD4 cells promote a protective immune
response, the CD8 cells remain in the blood for a long
time and inhibit the replication of the virus in
infected cells."
https://tinyurl.com/2p8tscmx
WIKI: "In 2020, BioNTech, partnering
with Pfizer for testing and logistics, developed the RNA
vaccine BNT162b2 for preventing COVID-19 infections,
which at the time offered a 91% efficacy." -
https://en.wikipedia.org/wiki/BioNTech
Whistleblower,
Prof. Ulrike Kammerer - Coronona Investigative Committee
BioNTech CEO Ugur Sahin admits deliberate selection of Lipid
Nanoparticles that do not remain at the injection site in the
arm but migrate to the lymph nodes.
"For the
Covid-19 candidate vaccine, we chose lipid nanoparticles
that promote migration from the muscle cells into the
lymph nodes." - BioNTech
CEO Ugur Sahin
Prof.
Ulrike Kammerer Deposition
https://odysee.com/@Corona-Investigative-Committee:5/session-82-en:1?r=8cSGjqEoyncQGynLZgG9WAbC61LaBPpT&t=15906
https://tinyurl.com/4n63r5n9
See TOWN SQUARE NEWS Updates: https://groups.google.com/g/town-square-news
